ArticleBMC primary care2025
Evaluate effects of the National Essential Public Health Service Program on hypertension control of Chinese community-dwelling people during the COVID-19 epidemic: a population-based multi-centre retrospective longitudinal study.
Article in BMC primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe National Essential Public Health Service Program was launched in 2009 to improve hypertension control of Chinese adults in primary care settings. Current research evidence regarding effectiveness of the National Essential Public Health Service Program on hypertension control during the COVID-19 epidemic was limited. To fulfil the research gap, this study aimed to evaluate hypertension control of the National Essential Public Health Service Program during the COVID-19 epidemic. It was anticipated that our study findings could demonstrated whether the National Essential Public Health Service Program was effective on hypertension control during the COVID-19 epidemic, which could provide policy making guidance on whether strategies to improve hypertension control of the National Essential Public Health Service Program during epidemics were necessary.
methodThis study was designed as a retrospective longitudinal study. People registering with the NEPHSP as hypertensive patients and consistently accepted hypertension care services of the NEPHSP between January 1, 2019 to January 8, 2023 were included in this study. The participants were included from 1393 primary care settings in 14 districts. The study outcomes included clinical, lifestyle, and anti-hypertensive treatment indicators. The study data were extracted from the structural patient information recorded in the Residence Health Record System. Using Generalized Estimating Equations model, we evaluated the hypertension control of the National Essential Public Health Service Program during the COVID-19 epidemic.
results411183 participants were included. Systolic blood pressure and diastolic blood pressure mean values increased by 1.83 mm Hg (95% CI, 1.78 to 1.88, P < 0.001) and 0.04 mm Hg (95% CI, 0.01 to 0.07, P < 0.001) during the COVID-19 epidemic. Systolic blood pressure and diastolic blood pressure control rates decreased by 7.92% (-0.35, 95% CI, -0.36 to -0.34, P < 0.001) and 8.27% (-0.31, 95% CI, -0.33 to -0.30, P < 0.001). Cardiovascular and cerebrovascular diseases diagnosis increased 8.04% (0.60, 95% CI, 0.58 to 0.61, P < 0.001) and 6.24% and (0.69, 95% CI, 0.68 to 0.71, P < 0.001) during the COVID-19 epidemic.
conclusionHypertension control of the National Essential Public Health Service Program declined during the COVID-19 epidemic. Structural telemedicine systems should be predefined to ensure efficient delivery of hypertension care services during epidemics. Strategies for ensuring timely referral and mental health interventions should be performed during epidemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.